DURECT (NASDAQ:DRRX) Now Covered by Analysts at StockNews.com
StockNews.com initiated coverage on shares of DURECT (NASDAQ:DRRX – Free Report) in a research note released on Thursday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. DURECT Stock Performance NASDAQ DRRX opened at $0.81 on Thursday. DURECT has a fifty-two week low of $0.70 and a fifty-two week high of $1.88. […]
StockNews.com initiated coverage on shares of DURECT (NASDAQ:DRRX – Free Report) in a research note released on Thursday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. DURECT Stock Performance NASDAQ DRRX opened at $0.81 on Thursday. DURECT has a fifty-two week low of $0.70 and a fifty-two week high of $1.88. […]
